Development and Validation of the Coronary Heart Disease Scale Among the System of Quality of Life Instruments for Chronic Diseases QLICD-CHD (V2.0) Based on Classical Test Theory and Generalizability Theory
DOI: https://doi.org/10.2147/ijgm.s447752
IF: 2.145
2024-05-08
International Journal of General Medicine
Abstract:Liyuan Qiao, 1, 2, &ast Shulin Ding, 2, &ast Wanrui Ma, 1 Chuanzhi Xu, 3 Xiaoqing Zhang, 3 Yuxi Liu, 1, 2 Chonghua Wan 1, 2 1 The First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan, people's republic of china; 2 Key Laboratory for Quality of Life and Psychological Assessment and Intervention, School of Humanities and Management, Guangdong Medical University, Dongguan, people's republic of china; 3 School of Public Health, Kunming Medical University, Kunming, people's republic of china &astThese authors contributed equally to this work Correspondence: Yuxi Liu; Chonghua Wan, Email ; Objective: Coronary heart disease (CHD) is a common and frequent disease with a long and incurable course, and the quality of life of patients is severely reduced. This study was to develop and validate a quality of life scale for patients with CHD based on the Chinese context. Methods: The scale QLICD-CHD (V2.0) was developed based on the QLICD-CHD (V1.0), using a programmed decision procedures. Based on the data measuring QoL 3 times before and after treatments from 189 patients with CHD, the psychometric properties of the scale were evaluated with respect to validity, reliability and responsiveness employing correlation analysis, multi-trait scaling analysis, structural equation modeling, t-test and also G-study and D-study of generalizability theory analysis. The SF-36 scale was used as the criterion to evaluate the criterion-related validity. Paired t tests were conducted to evaluate the responsiveness on each domain/facet as well as the total of the scale, with Standardized Response Mean (SRM) being calculated. Results: The QLICD-CHD (V2.0) has been developed with 42 items in 4 domains. The Cronbach's α of the general module, the specific module and the total scale were 0.91, 0.92 and 0.91 respectively. The overall score and the test-retest reliability coefficients in all domains are higher than 0.60, except for the specific module. Correlation and factor analysis confirmed good construct validity and criterion-related validity. After treatments, the overall score and score of all domains have statistically significant changes (P< 0.01). The SRM of domain-level score ranges from 0.27 to 0.50. Generalizability Theory further confirm the reliability of the scale through more accurate variance component studies. Conclusion: The QLICD-CHD (V2.0) could be used as a useful instrument in assessing QoL for patients with CHD, with good psychometric properties. Keywords: quality of life, classical test theory, standardized response mean, psychometric properties, generalizability theory Coronary heart disease (CHD) is a chronic condition characterized by myocardial dysfunction and/or organic lesions caused by narrowing of the coronary arteries and insufficient blood supply. 1 According to the latest statistics, CHD is the leading single cause of mortality and Disability Adjusted Life Year (DALY) lost worldwide. A large proportion of this burden occurs in low- and middle-income countries. It is responsible for nearly 7 million deaths and 129 million DALYs annually and represents a significant global economic burden. 2 In recent decades, with the improvement of people's living standards, the accelerated pace of life and the aggravation of social pressure, the morbidity and mortality of CHD in China have shown a rapidly increasing trend. 3 At present, CHD is the fastest rising cause of death among Chinese residents and is the disease with the highest rate of death and disability in China. 4,5 The pathogenesis of CHD is complex and difficult to cure, patients often need to endure long-term pain and need to be strictly supervised by doctors, patients are usually difficult to have a high quality of life(QoL), so to improve the QoL of patients with CHD has also become the primary goal of researchers and doctors. 6,7 Tools for assessing health needs and QoL are increasingly being developed to assess specific areas and levels of need within defined time frames as a means of improving the QoL and programs of care for patients, particularly in the area of chronic diseases such as cancer 8,9 and cardiovascular disease. 10 Quality of life in patients with coronary artery disease is usually assessed using generic and specific scales. The main generic scales are SF-36, sickness impact profile (SIP), Nottingham health profile (NHP), the EuroQoL-5 dimensions (EQ-5D), 11 World Health Organization Quality of Life −100 scale (WHOQOL-100), WHOQOL-BREF, and so on. Generic scales only take into a -Abstract Truncated-
medicine, general & internal